| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 181 | PROBIOTIC CONTAINING MODULES FOR TUBE FEEDING | US13319941 | 2010-05-11 | US20120195867A1 | 2012-08-02 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding modules comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | ||||||
| 182 | ORAL NUTRITIONAL SUPPLEMENT COMPRISING PROBIOTICS | US13319653 | 2010-05-11 | US20120183515A1 | 2012-07-19 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | ||||||
| 183 | INFANT CEREAL COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS | US13319651 | 2010-05-11 | US20120183514A1 | 2012-07-19 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 184 | INSTANT THICKENER COMPRISING PROBIOTICS FOR HOT OR COLD FOODS AND BEVERAGES TO BE ADMINISTERED TO DYSPHAGIC PATIENTS | US13319959 | 2010-05-11 | US20120135044A1 | 2012-05-31 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the fields of hydration and nutrition for dysphagic patients. In particular, the present invention relates to thickeners comprising probiotic microorganisms and to compositions comprising such thickeners. The probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic microorganisms. | ||||||
| 185 | COMPLETE LIQUID NUTRITION FOR CHILDREN AT THE AGE OF 1-10 YEARS COMPRISING PROBIOTICS | US13319961 | 2010-05-11 | US20120121652A1 | 2012-05-17 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 186 | BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS | US13319649 | 2010-05-07 | US20120114701A1 | 2012-05-10 | Valerie Petit; Clara Garcia-Rodenas; Monique Julita; Guenolee Prioult; Annick Mercenier; Sophie Nutten |
| The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM I-2618) for use in the treatment or prevention of disorders related to the immune system including infections. | ||||||
| 187 | SPECIALIZED MEDICAL NUTRITION FOR SURGICAL AND TRAUMA PATIENTS CONTAINING PROBIOTICS | US13319953 | 2010-05-11 | US20120107287A1 | 2012-05-03 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of specialized nutritional compositions. In particular, the present invention provides nutritional compositions for providing complete nutrition to hospitalized patients comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | ||||||
| 188 | COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF | US13145656 | 2010-01-27 | US20110280848A1 | 2011-11-17 | Rachid Bel-Rhlid; Vanessa Crespy; Thomas Wolfgang Raab; Nicole Page-Zoerkler; Rene Fumeaux; Maricel Marin-Kuan; Dominique Piguet |
| The present invention relates generally to the field of food and drinks. In particular, for example, a composition is provided that allows to provide tartaric and/or caffeic acid to a subject. One embodiment of the present invention is a composition comprising an ingredient containing chicoric acid and/or derivatives thereof, and a lactic acid bacterium capable of hydrolysing chicoric acid and/or derivatives thereof to generate tartaric and/or caffeic acid. | ||||||
| 189 | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions | US10362249 | 2001-09-21 | US07498162B2 | 2009-03-03 | Jacques Edouard Germond; Blaise Corthesy; Beat Mollet; Rodolphe Fritsche |
| The present invention pertains to novel strains of lactic acid bacteria that are capable to reduce an individual's tendency to mount allergic reactions. In particular, the present invention relates to the generation of lactic acid bacteria strains that express proteins including tolerogenic peptides and the use thereof in reducing an individual's tendency to mount allergic reactions. The invention also pertains to food or pharmaceutical compositions containing said micro-organisms or active fractions thereof. | ||||||
| 190 | METHODS OF PREVENTING PERITONITIS BY ADMINISTERING LACTIC ACID BACTERIUM | US11697518 | 2007-04-06 | US20070172512A1 | 2007-07-26 | Eduardo Schiffrin; Carlos Guarner; German Soriano |
| The present invention relates to the use of lactic acid bacteria capable of adhering to the mucosa of the intestine and especially colonizing it for the prevention of peritonitis. In particular, the present invention relates to the use of such lactic acid bacteria for the prevention of peritonitis caused by cirrhosis of the liver. Specifically, the present invention relates to a method for preventing peritonitis in a patient in need of such prevention. This method includes administering to the patient a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The invention also relates to a peritonitis preventing composition of a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The carrier is preferably a food or pharmaceutical composition. | ||||||
| 191 | 다양한 기능성을 가진 신규 유산균 및 이의 용도 | KR1020160114842 | 2016-09-07 | KR101889281B1 | 2018-08-21 | 한명주; 김동현 |
| 본발명은김치또는사람의분변에서분리된신규락토바실러스속균주, 신규비피도박테리움속균주또는이들의혼합유산균을제공한다. 본발명에따른특정락토바실러스속균주또는특정비피도박테리움속균주는김치또는사람의분변에서분리되어안전성이높고항산화활성, 베타-글루쿠로니다제(β-glucuronidase) 저해활성, 지질다당류(lipopolysaccharide, LPS) 생성억제활성또는밀착연접단백질(tight junction protein) 발현유도활성등과같은다양한생리활성을갖는다. 따라서, 본발명에따른특정락토바실러스속균주, 특정비피도박테리움속균주또는이들의혼합유산균은장 손상, 간손상, 알러지질환, 염증질환, 또는비만등을예방, 개선또는치료하는데에유용한기능성식의약소재로사용될수 있다. | ||||||
| 192 | 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물 | KR1020160114319 | 2016-09-06 | KR1020170032845A | 2017-03-23 | 한명주; 김동현 |
| 본발명은김치에서분리되어안전성이높고기억력개선활성, 밀착연접단백질(tight junction protein) 발현유도활성, 항산화활성, 지질다당류(lipopolysaccharide, LPS) 생성억제활성또는베타-글루쿠로니다제(β-glucuronidase) 저해활성등과같은다양한생리활성을갖는신규유산균및 이의용도를제공한다. 본발명에따른신규유산균은퇴행성뇌질환또는인지기능장애의예방, 개선또는치료를위한기능성식의약소재로사용될수 있다. | ||||||
| 193 | 위산 및 가스트린의 생산을 저해하는 유산균 | KR1020110135243 | 2011-12-15 | KR101451188B1 | 2014-10-15 | 나카노야스히로; 아이바유지; 구마가이미치히코; 아스카베후미야; 고가야스히로 |
| 본 발명은 유산균(예, 락토바실러스 존소니이(
Lactobacillus
johnsonii ) No. 1088)의 생균 또는 사균을 생체에 투여함으로써, 위액 중의 산 농도를 감소시키고, pH의 강산성화를 억제하고, 가스트린의 생산을 억제하는 방법에 관한 것이다. 또한, 유산균의 생균 또는 사균을 생체에 투여함으로써, 프로톤 펌프 저해제의 계속 투여로 인한 부작용을 완화하는 방법에 관한 것이다.
|
||||||
| 194 | 장세포의 미네랄 흡수 | KR1020007000073 | 1998-06-26 | KR1020010015563A | 2001-02-26 | 브라싸르도미니크; 베이엘리자베쓰 |
| 음식물로부터의미네랄흡수를증가또는촉진시키는방법. 락토바실리를함유하는영양조성물을포유동물에서장을경유하도록투여한다. 영양조성물은미네랄결핍증을갖는환자를치료또는예방하거나, 낮은미네랄섭취로인한생리학적결핍을보충하거나, 또는어린이, 임산부, 수유중인여성및 노인에서미네랄에대한대부분의생리학적요구량을만족시키기에적합하다. | ||||||
| 195 | NOVEL LACTOBACILLUS HAVING VARIOUS FUNCTIONS, AND USE THEREOF | EP16846789.2 | 2016-09-07 | EP3351617A1 | 2018-07-25 | KIM, Dong Hyun; HAN, Myung Joo |
The present invention provides novel Lactobacillus sp. strains, novel Bifidobacterium sp. strains, or lactic acid bacteria mixtures thereof, which are isolated from kimchi or human feces. A certain Lactobacillus sp. strain or certain Bifidobacterium sp. strain according to the present invention is isolated from kimchi or human feces, and thus is highly safe, and has various physiological activities such as antioxidant activity, β-glucuronidase inhibitory activity, lipopolysaccharide (LPS) production inhibitory activity or tight junction protein expression-inducing activity. Accordingly, a certain Lactobacillus sp. strain, certain Bifidobacterium sp. strain or mixture thereof according to the present invention may be used as a functional food or medicinal material useful for the prevention, alleviation or treatment of intestinal damage, liver injury, allergic disease, inflammatory disease, or obesity. |
||||||
| 196 | INFANT AND YOUNG CHILDREN FEEDING FORMULA COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS | EP10718196.8 | 2010-05-11 | EP2429540B1 | 2016-07-27 | MERCENIER, Annick; NUTTEN, Sophie; PRIOULT, Guénolée |
| The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 197 | INFANT FEEDING FORMULAS COMPRISING PROBIOTIC MICRO-ORGANISMS | EP10747838.0 | 2010-05-11 | EP2429557B1 | 2016-05-04 | MERCENIER, Annick; NUTTEN, Sophie; PRIOULT, Guénolée |
| The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 198 | Compositions for the inhibition of Giardia Lamblia | EP14306265.1 | 2014-08-08 | EP3011966A1 | 2016-04-27 | Bermudez-Hiumaran, Luis G.; Allain, Thibault; Florent, Isabelle; Langella, Philippe; Grellier, Philippe; Travers, Marie-Agnès |
The present invention relates to a composition exhibiting a bile-salt hydrolase activity for its use for the treatment or the prevention of giardiasis, said composition comprising a bile-salt hydrolase (BSH) enzyme, a bacterium able to secrete a BSH, a recombinant host cell able to secrete a BSH, or a combination thereof. The present invention also relates to the use of a composition exhibiting a BSH activity for the treatment or the prevention of giardiasis, and to a pharmaceutical composition or a food composition comprising, as an active principle, a BSH, a lactic acid bacterium able to secrete a BSH, or a recombinant host cell able to secrete a BSH. |
||||||
| 199 | NON-REPLICATING BIFIDOBACTERIUM LONGUM NCC2705 AND IMMUNE DISORDERS | EP10717656.2 | 2010-05-07 | EP2429538B1 | 2015-10-21 | PETIT, Valérie; GARCIA-RODENAS, Clara; JULITA, Monique; PRIOULT, Guénolée; MERCENIER, Annick; NUTTEN, Sophie |
| The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 200 | PROBIOTIC AND POLYPHENOL AGAINST NEURODEGENERATION | EP13729784.2 | 2013-06-20 | EP2863929A1 | 2015-04-29 | BEL-RHLID, Rachid; DURGA, Jane; KUNZ, Tina; SCHMITT, Jeroen, Antonius, Johannes |
| The present invention relates to a composition comprising the probiotic strain Lactobacillus johnsonii CNCM I-1225 in combination with a polyphenol for use in the treatment or prevention of a cognitive and/or neurodegenerative disorder, in particular Alzheimer's disease. | ||||||
QQ群二维码
意见反馈
意见反馈